Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
CL ›
CLEMDARIX
Trademark search for:
CLEMDARIX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2000-10-18 — Application filed
2001-03-26 — Assigned to examiner
2001-03-29 — Final disposition recorded
2001-09-27 — Correspondence received in law office
2001-09-27 — Correspondence received in law office
2001-11-05 — Letter of suspension mailed
2001-11-05 — Assigned to examiner
2002-10-21 — Assigned to examiner
2002-11-18 — Inquiry as to suspension mailed
2003-05-19 — Paper received
2003-05-19 — Correspondence received in law office
2003-07-21 — Approved for pub - principal register
2003-09-03 — Notice of publication
2003-09-23 — Published for opposition
2003-12-16 — Noa mailed - sou required from applicant
2004-05-11 — Sou teas extension received
2004-05-11 — Sou extension 1 filed
2004-05-17 — Case file in ticrs
2004-05-20 — Sou extension 1 granted
2004-11-18 — Sou teas extension received
2004-11-18 — Sou extension 2 filed
2004-11-24 — Sou extension 2 granted
2005-06-02 — Sou teas extension received
2005-06-02 — Sou extension 3 filed
2005-06-02 — Sou extension 3 granted
2005-12-17 — Final status recorded
2006-02-22 — Application abandoned
2006-02-22 — Application abandoned
Owner Information
GlaxoSmithKline Biologicals S.A.
B-1330 Rixensart BE
SmithKline Beecham Biologicals S.A.
Rixensart BE
SmithKline Beecham Biologicals S.A.
Rixensart BE
Correspondent
PAMELA A MAY GLAXOSMITHKLINE UW2221 709 SWEDELAND RD KING OF PRUSSIA, PA 19406-0939
Filing Details
Filing Date:
2000-10-18
Status Date:
2005-12-17
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.